Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 30744
Evènement :What To Expect From FDA’s New Approach to Regulate Medical Software

Date :Mardi 17 Décembre 2019

Lieu :Palo Alto
2479 East Bayshore Road,
Suite 200
94303 Palo Alto, California, États-Unis

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--


 

Informations

Editorial

The FDA’s emerging approach to medical software product regulation has important ramifications for patients, healthcare providers and insurers as well as product developers. So, it is critically important for companies throughout the life sciences and healthcare industries that utilize software in its products to understand the important challenges and opportunities presented by this major policy shift. This webinar will provide understanding.
 

Objectives

  • FDA’s history in regulating medical software
  • Evolution of FDA’s regulatory framework
  • 21st Century Cures Act clarifies FDA jurisdiction
  • Software functions excluded from medical device oversight
  • Medical software as a medical device (SaMD) and software in a medical device (SiMD)
  • Overview of FDA’s Digital Health Innovation Action Plan
  • FDA’s Software Recertification Program and 2019 Test Plan
  • Summary of FDA’s new regulatory framework
  • Role of stakeholders in FDA’s revised
  • What are the FDA’s next steps
  • Key questions about FDA’s streamlined regulatory approach
  • Implications for health software industry

Program

The following professionals from Life sciences companies (Pharma & Drugs; Quality Management; FDA Compliance; Medical Devices & Compliance), and Hospital & Healthcare Companies (General Healthcare; Healthcare IT & Data Security and Legal & Audits)

  • Regulatory Directors/Managers
  • Medical Software/Digital Health Company Executives & Managers
  • Medical Software Design & Specification Developers
  • Real-Time Software Performance Auditors
  • Medical Software R&D Directors & Managers
  • Business Planning Executives
  • In-house Medical Software Product Legal Counsel
  • Law Firm Counsels Specializing in FDA Policy
  • Hospital & Healthcare Risk Managers
  • Customer Support & Service Directors
 


 

Speakers

President, Dennis Weissman and Associates LLC
 

Lieu

Plan et itinéraire
Adresse de la conférence :
Palo Alto
2479 East Bayshore Road,
Suite 200
94303 Palo Alto
California, États-Unis
Tél : +1-888-717-2436
Plan et itinéraire

Renseignements

Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama

Précisions

What To Expect From FDA’s New Approach to Regulate Medical Software Management
"medical software, medical software product regulation, digital health pre-certification, digital health pre-certification (pre-cert) program, medical software as a medical device (samd) and software in a medical device (simd), medical device oversight, fda’s software recertification program and 2019 test plan"
Professionnels
3 -- --
English

Divers

Pour plus d'informations sur What To Expect From FDA’s New Approach to Regulate Medical Software, veuillez contacter ComplianceOnline

Pour afficher le site de l'annonceur, obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama


Recommander cet évènement